ArticleFrontiers in oncology2026
Cytoreductive surgery for ovarian cancer with pelvic ectopic kidney: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pelvic ectopic kidney is a rare congenital anomaly, occurring in approximately 0.1% of the adult population, and is often asymptomatic. However, it can easily be mistaken for a pelvic tumor or lymph-node metastasis. This case report details a rare presentation of cytoreductive surgery for ovarian cancer with a pelvic ectopic kidney. A 56-year-old Chinese woman was incidentally found to have a pelvic mass accompanied by a pelvic ectopic kidney during evaluation for hip pain. Pathology following cervical lymph-node biopsy was consistent with high-grade serous adenocarcinoma. Comprehensive assessment via supraclavicular lymph-node biopsy, PET-CT, and multidisciplinary team (MDT) discussion confirmed ovarian cancer stage IVb with coexisting pelvic ectopic kidney. Treatment consisted of neoadjuvant chemotherapy with paclitaxel plus carboplatin followed by interval cytoreductive surgery achieving complete resection of all pelvic and abdominal lesions. Postoperative pathology verified high-grade serous ovarian carcinoma, stage IVb. Serum creatinine on postoperative day 1 was 78 µmol/L and remained stable; the patient was discharged on day 12. Post-discharge renal scintigraphy showed no decline in total GFR, and no renal or surgical complications occurred. This case underscores the importance of MDT management and thorough diagnostic work-up when performing cytoreductive surgery for ovarian cancer in the setting of pelvic ectopic kidney. Increased clinical awareness of this scenario helps avoid misdiagnosis, optimizes patient outcomes, and provides a reproducible technical roadmap for similar complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.